Key result
Cytochalasin B disruption of the actin cytoskeleton significantly attenuated Angiotensin II-mediated ROS formation (p<0.01) and activation of p38MAP kinase and JNK (p<0.05) in human VSMCs.
The actin cytoskeleton plays a critical role in mediating Angiotensin II-induced ROS formation and activation of specific MAP kinases (p38 and JNK) in human vascular smooth muscle cells.
Answers are grounded in this paper and cite their sources.
Actin disruption attenuates Ang II signaling in VSMCs; hypothesis-generating for cytoskeletal targets, should not yet change practice.
Angiotensin II (Ang II) regulates vascular smooth muscle cell (VSMC) function by activating signaling cascades that promote vasoconstriction, growth, and inflammation. Subcellular mechanisms coordinating these processes are unclear. In the present study, we questioned the role of the actin cytoskeleton in Ang II mediated signaling through mitogen-activated protein (MAP) kinases and reactive oxygen species (ROS) in VSMCs. Human VSMCs were studied. Cells were exposed to Ang II (10-7 mol/L) in the absence and presence of cytochalasin B (10-6 mol/L, 60 min), which disrupts the actin cytoskeleton. Phosphorylation of p38MAP kinase, JNK, and ERK1/2 was assessed by immuno blotting. ROS generation was measured using the fluoroprobe chloromethyl-2',7'-dichlorodihydrofluorescein diacetate (4 micromol/L). Interaction between the cytoskeleton and NADPH oxidase was determined by evaluating the presence of p47phox in the Triton X-100 insoluble membrane fraction. Ang II significantly increased phosphorylation of p38MAP kinase, JNK, and ERK1/2 (two- to threefold above control, p < 0.05). Cytochalasin B pretreatment attenuated p38MAP kinase and JNK effects (p < 0.05) without altering ERK1/2 phosphorylation. ROS formation, which was increased in Ang II stimulated cells, was significantly reduced by cytochalasin B (p < 0.01). p47phox, critically involved in NADPH oxidase activation, colocalized with the actin cytoskeleton in Ang II stimulated cells. Our data demonstrate that Ang II mediated ROS formation and activation of p38MAP kinase and JNK, but not ERK1/2, involves the actin cytoskeleton in VSMCs. In addition, Ang II promotes interaction between actin and p47phox. These data indicate that the cytoskeleton is involved in differential MAP kinase signaling and ROS generation by Ang II in VSMCs. Together, these studies suggest that the cytoskeleton may be a central point of crosstalk in growth- and redox-signaling pathways by Ang II, which may be important in the regulation of VSMC function.
No takes yet. Share an insight, caveat, or question.
Touyz et al. (2005) studied this question. Cytochalasin B pretreatment prior to Angiotensin II exposure vs. Angiotensin II alone (absence of cytochalasin B) was evaluated on Phosphorylation of p38MAP kinase, JNK, and ERK1/2, and ROS generation (p=< 0.05). Cytochalasin B disruption of the actin cytoskeleton significantly attenuated Angiotensin II-mediated ROS formation (p<0.01) and activation of p38MAP kinase and JNK (p<0.05) in human VSMCs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: